Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 41.30
+0.10 (0.24%)
Aug 4, 2026, 12:54 PM CST
TPEX:6864 Market Cap
TPEX:6864 has a market cap or net worth of 1.59 billion as of August 4, 2026. Its market cap has decreased by -42.43% in one year.
Market Cap
1.59B
Enterprise Value
1.12B
Revenue
706.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
41.30
ChartMarket Cap Chart
Since December 29, 2021, TPEX:6864's market cap has increased from 1.50B to 1.59B, an increase of 5.90%. That is a compound annual growth rate of 1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.59B | -43.36% |
| Dec 31, 2025 | 2.80B | 42.37% |
| Dec 31, 2024 | 1.97B | 210.82% |
| Dec 29, 2023 | 633.75M | -17.29% |
| Dec 30, 2022 | 766.25M | -45.27% |
| Dec 30, 2021 | 1.40B | -6.67% |
| Dec 29, 2021 | 1.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gwo Xi Stem Cell Applied Technology Co. , | 1.91B |
| G&E Herbal Biotechnology | 1.86B |
| Sunny Pharmtech | 1.82B |
| Greenyn Biotechnology | 1.66B |
| Synbio Tech | 1.59B |
| TaiRx | 1.51B |
| Andros Pharmaceuticals Co.,Ltd | 1.43B |
| Advagene Biopharma | 1.41B |